Contract W911QY20C0084
Inovio Pharmaceuticals, Inc. · Department Of Defense · September 29, 2021
Inovio Pharmaceuticals, Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on September 29, 2021 for $16.57 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Plymouth Meeting, PA. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $16.57 million.
Contract details
- PIID
- W911QY20C0084
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Plymouth Meeting, PA
- First action
- September 29, 2021
Description
CELLECTRA 2000 ARRAY
Modification timeline
-
September 29, 2021Mod P00002 · Other Administrative Action$16.57M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Avian, Llc | Department Of Defense | December 31, 2025 | $54.05M |
| Rtx Bbn Technologies, Inc. | Department Of Defense | December 29, 2025 | $4.36M |
| Council On Strategic Risks (The) | Department Of Defense | December 23, 2025 | $356.6K |
| Eagle Integrated Services, Llc | Department Of Defense | December 23, 2025 | $1.93M |
| Ssi-Venesco Jv Llc | Department Of Defense | December 23, 2025 | $144.5K |
| Techwerks Llc | Department Of Defense | December 23, 2025 | $2.21M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W911QY20C0084?
Contract W911QY20C0084 is a federal contract awarded to Inovio Pharmaceuticals, Inc. by Department Of Defense on September 29, 2021 for $16.57 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract W911QY20C0084?
Inovio Pharmaceuticals, Inc. won contract W911QY20C0084 from Department Of Defense.
How much is contract W911QY20C0084 worth?
Contract W911QY20C0084 has obligated $0 to date but carries a potential ceiling of $16.57 million if fully funded and all options are exercised.